MYLAN ONDANSETRON can have side effects. Not all side effects reported for MYLAN ONDANSETRON are included in this leaflet. Should your general health worsen or if you experience any untoward effects while taking MYLAN ONDANSETRON, please consult your healthcare provider for advice.
If any of the following happens, stop receiving MYLAN ONDANSETRON and tell your doctor immediately or go to the casualty department at your nearest hospital:
- sudden wheezing and chest pain or chest tightness;
- swelling of your eyelids, face, lips, mouth, throat or tongue;
- low blood pressure (which can make you feel lightheaded or dizzy);
- skin rash - red spots or lumps under your skin (hives) anywhere on your body;
- shock;
- myocardial ischemia with symptoms such as sudden chest pain and chest tightness.
These are all very serious side effects. If you have them, you may have had a serious allergic reaction to MYLAN ONDANSETRON. You may need urgent medical attention or hospitalisation.
Tell your doctor immediately or go to the casualty department at your nearest hospital if you notice any of the following:
- an uneven heartbeat or disturbance in your heart rhythm;
- chest pain;
- fits (seizures).
These are all serious side effects. You may need urgent medical attention.
Tell your doctor if you notice any of the following:
The following side effects have been reported frequently:
- headache;
- a feeling of warmth or flushing;
- changes to liver function test results (could be frequent if you receive MYLAN ONDANSETRON with a cancer medicine called cisplatin).
The following side effects have been reported less frequently:
- constipation;
- pain, redness and burning at the site of injection;
- unusual body movements or shaking;
- dizziness (during rapid intravenous administration);
- blurred or poor vision or temporary loss of eyesight;
- depression;
- hiccups.
If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Reporting of side effects
If you get side effects, talk to your doctor, pharmacist or nurse. Reporting suspected adverse reactions after authorisation of the medicine is important. It allows continued monitoring of the benefit/risk balance of the medicine. Healthcare providers are asked to report any suspected adverse reactions to SAHPRA via the “6.04 Adverse Drug Reactions Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8. By reporting side effects, you can help provide more information on the safety of MYLAN ONDANSETRON.